Compare CAVA & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAVA | BCPC |
|---|---|---|
| Founded | 2006 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2023 | N/A |
| Metric | CAVA | BCPC |
|---|---|---|
| Price | $48.97 | $156.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | $79.56 | ★ $190.00 |
| AVG Volume (30 Days) | ★ 5.1M | 160.3K |
| Earning Date | 11-04-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ 151.16 | 22.48 |
| EPS | 1.16 | ★ 4.57 |
| Revenue | ★ $1,132,074,000.00 | $1,013,548,000.00 |
| Revenue This Year | $24.73 | $10.31 |
| Revenue Next Year | $21.88 | $5.89 |
| P/E Ratio | $42.17 | ★ $34.16 |
| Revenue Growth | ★ 23.93 | 7.55 |
| 52 Week Low | $43.41 | $139.17 |
| 52 Week High | $153.34 | $181.94 |
| Indicator | CAVA | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 55.36 |
| Support Level | $46.26 | $151.97 |
| Resistance Level | $51.15 | $158.05 |
| Average True Range (ATR) | 2.47 | 2.94 |
| MACD | 0.81 | 0.05 |
| Stochastic Oscillator | 72.74 | 63.46 |
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.